This toolkit brings together data from the Swedish Institute of Health Economics’ Comparator Report on Cancer in Europe 2019, providing a visual and interactive comparison of cancer care and outcomes across European countries.

It compares findings across European countries in terms of incidence, mortality, survival, spending and medicines uptake for the following cancer types:

  • Colorectal cancer
  • Lung
  • Malignant melanoma
  • Breast
  • Ovarian
  • Prostate
  • Lymphoid (Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, multiple myeloma, leukaemia)
  • Pancreatic


The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA's mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.

Our vision is for a healthier future for Europe. A future based on prevention, innovation, access to new treatments and better outcomes for patients.


This interactive toolkit allows you to compare cancer outcomes across European countries according to incidence, survival, mortality, spending and medicines uptake, or according to cancer type.

By clicking on the tabs at the top of the page, you will be taken to the relevant page. The interactive maps on the incidence and mortality pages allow you to access the corresponding incidence or mortality data for that country. The interactive map on the survival page allows you to see how many lives would be saved in each country, if that country achieved the best survival rate for colon cancer in Europe.

On each page, you can access cancer-specific data by clicking on the icons at the bottom of the page.

Each cancer-specific section can be accessed by clicking the relevant button at the top of the page under ‘Cancer Types’.

Below each graph, there is a ‘Data’ button, which allows you to download the full corresponding data set.


Cancer incidence data sources
ECIS (European Cancer Information System). Incidence and mortality estimates 2018
ECIS (European Cancer Information System). Incidence and mortality historical data
Engholm, G et al. NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 8.0 (20.12.2017)

Cancer mortality data sources
ECIS (European Cancer Information System). Incidence and mortality estimates 2018
International Agency for Research on Cancer. WHO cancer mortality database

Cancer survival data sources
Allemani, C et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Allemani, C et al. Global surveillance of trends in cancer survival 2000-2014 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Cancer medicines data sources
Hofmarcher, T et al. (2019) Comparator Report on Cancer in Europe 2019 - Disease Burden, Costs and Access to Medicines.
IHE Report 2019:7. IHE: Lund, Sweden


"This work uses data provided by patients and collected as part of their care and support"

Adapted from the use MY data Patient Data Citation, UK